EMCDDA Home
  • EN

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (i) New outpatient clients, age at first use distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opiates6.738.030.012.96.43.11.51.322.4294645049
Cocaine8.438.326.713.26.73.91.91.022.4254702422
Stimulants14.954.318.36.33.10.80.81.620.03352435
Hypnotics and sedatives8.622.615.911.910.211.69.110.129.01085229
Hallucinogens6.420.313.410.99.39.010.020.832.1659134
Volatile substances38.227.615.62.59.50.04.52.020.419926
Cannabis 38.848.78.32.40.90.50.20.217.0253843588
Other substances 21.732.717.05.27.08.73.54.223.4575912
Total17.241.521.79.54.82.71.41.220.98618812795

Notes:

 Countries reporting data: BE, BG, CZ, DK, DE,EE, IE, EL, ES, FR, IT, CY, LV, HU, MT, NL, AT, RO, SI, SK, FI, SE, HR 

 Last data available from Spain refer to 2007, for Malta refer to 2006 and for Belgium refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-106 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 14 July 2010